Sepsis-induced cardiac dysfunction, lung edema, and declined anti-inflammatory responses can be reversed by genetic ablation or pharmacological inhibition of sphingomyelin phosphodiesterase (SMPD1) and Sphk in septic rodents (118, 124, 125, 126). This evidence concerns the gene SMPD1 and Sepsis.